Patient education programme for early multiple sclerosis (MS)
Effectiveness of a patient education program about diagnosis, prognosis and early treatment in multiple sclerosis: a randomised controlled trial
What it found
A paper reports the results; we have not read it yet. See Papers below.
What it measured
Main measures
Informed choice (IC) about initiation or continuation of immunotherapies after 6 months of follow-up using an adaptation of the Multidimensional Measure of Informed Choice (MMIC), comprising appropriate disease-related risk-knowledge and consistency between attitude and decision.
Other measures (1)
1. Control beliefs, assessed 2 weeks before the intervention and at the end of follow-up using the German questionnaire on control beliefs in illness (KKG) 2. Decision autonomy, assessed 2 weeks before the intervention and at the end of follow-up using the using a previously used scale based on the Control Preference Scale 3. Decision conflict and satisfaction with the decision will be assessed 2
Mood and sleepQuality of life (reported by participants)Safety
Who could take part
Relapsing MS · 18 and over
Show the full criteria
Inclusion criteria
Inclusion: 1. Possible or definite relapsing form of MS following revised McDonald criteria 2. Diagnosis within the last 12 months 3. Aged 18 - 60 years, either sex Exclusion: 1. Major cognitive deficit 2. Progressive form of MS
Exclusion criteria
Not separately supplied in the registry.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Not provided at time of registration
Papers
Results
Applying the theory of planned behaviour to multiple sclerosis patients' decisions on disease modifying therapy--questionnaire concept and validation.BMC Med Inform Decis Mak · 2012
Results
results
Loading reviews and guidelines…
History
Started
Apr 2009
Finished
Apr 2011